Malaysia which offers attractive incentives and infrastructure for companies venturing into biotechnology can anticipate more collaboration with Indian biotech companies in future.

Malaysian Biotechnology Corporation's (BiotechCorp) Chief Executive Officer Datuk Iskandar Mizal Mahmood said with the facilities provided Indian companies should have no problem in expanding their operations here.

"We anticipate not just higher but more significant collaborations with the Indian fraternity," he said in a statement Wednesday in conjunction with BiotechCorp's participation at the three-day Bangalore India Bio 2010 conference and exhibition which began Wednesday.

Iskandar said Malaysia offered a strategic base for companies in active pharmaceutical ingredients, contract manufacturing, contract research organisation and medical device and diagnostics.

He said memorandum of understandings have been signed with two reputed Indian companies and global biotech giants, BioCon Ltd and Dr Reddy's Laboratories Ltd.

"The potential with BioCon will mark a significant progress for Malaysia in the area of biological products while collaboration with Dr Reddy's will explore a joint drug discovery research programme and the setting up of a pharmaceutical manufacturing facility in the country.

Read More....